Loading...
 
Back to the list
Mediterr J Rheumatol 2018;29(1):17-20
Article Links
New concepts in ANCA detection and disease classification in small vessel vasculitis: the role of ANCA antigen specificity
Elena Csernok
Authors Information

Department of Internal Medicine, Rheumatology and Immunology, Vasculitis-Center Tübingen-Kirchheim, Medius Klinik Kirchheim, University of Tübingen, Kirchheim-Teck, Germany

Keywords: proteinase 3-, myeloperoxidase- ANCA, methods, new recommendations, clinical significance
References
  1. Van der Woude F J, Rasmussen N, Lobatto S. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener’s granulomatosis. Lancet 1985; 1:425-9.
  2. Csernok E, Lamprecht P, Gross W L. Diagnostic significance of ANCA in vasculitis. Nat Clin Pract Rheumatol 2006; 2:174-5.
  3. Kallenberg C G M, Usefulness of antineutrophil cytoplasmic autoantibodies in diagnosing and managing systemic vasculitis. Rheumatology 2015; 28:1-14.
  4. Savige J et al. International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA). Am J Clin Pathol 1999; 111:507-13.
  5. Savige J et al. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases. Am J Clin Pathol 2013; 120:312-8.
  6. Cohen Tervaert J W, Damoiseaux J. Antineutrophil cytoplasmic autoantibodies: how are they detected and what is their use for diagnosis, classification and follow-up? Clin Rev Allergy Immunol 2012; 43: 211-9.
  7. Csernok E, Moosig F. Current and emerging techniques for ANCA detection in vasculitis. Nat. Rev. Rheumatol 2014; 10:494-501.
  8. Csernok E et al. Evaluation of automated multi-parametric indirect immunofluorescence assays to detect anti-neutrophil cytoplasmic antibodies (ANCA) in granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA). Autoimmun 2016; Rev. 15:736-41.
  9. Damoiseaux J et al. Detection of antineutrophil cytoplasmic antibodies (ANCAs): a multicentre European Vasculitis Study Group (EUVAS) evaluation of the value of indirect immunofluorescence (IIF) versus antigen-specific immunoassays. Ann Rheum Dis 2017; 76:647-53. 
  10. Hagen E C et al. Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis. EC/BCR Project for ANCA Assay Standardization. Kidney Int 1998; 53:743-53.
  11. Bossuyt X et al. Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol 2017; doi: 10.1038/nrrheum, 2017.140. [Epub ahead of print] 
  12. Bossuyt X et al. A multicentre study to improve clinical interpretation of proteinase-3 and myeloperoxidase anti-neutrophil cytoplasmic antibodies. Rheumatology 2017; doi: 10.1093/rheumatology/kex170. [Epub ahead of print]
  13. Arnold D F et al. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients. J Clin Pathol 2010; 63:678-80.
  14. Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U. ANCA-associated vasculitis – clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 2016; 12:570-9.
  15. Lyons P A et al. Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 2012; 367:214-23.
  16. Franssen C F et al. Antiproteinase 3- and antimyeloperoxidase-associated vasculitis. Kidney Int 2000; 57:2195-206.
  17. Schönermarck U, Lamprecht P, Csernok E, Gross W L. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2011; 40:178-84.
  18. Hauer H A, Bajema IM, van Houwelingen H C, Ferrario F, Noël LH, Waldherr R, et al. Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. Kidney Int 2002; 61:80-9. 
  19. Quintana L F, Peréz NS, De Sousa E et al. ANCA serotype and histopathological classification for the prediction of renal outcome in ANCA-associated glomerulonephritis. Nephrol Dial Transplant 2014; 19.
  20. Lionaki S et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 2012; 64:3452-62.
  21. Mahr A et al. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis. Ann Rheum Dis 2013; 72:1003-10.